(RTTNews) - Eledon Pharmaceuticals, Inc. (ELDN) announced on Monday that it has appointed Eliezer Katz as chief medical officer.
Katz is a transplant surgeon and was the chief medical officer of eGenesis. Prior to eGenesis he has held many senior roles in companies like Viela Bio, Horizon Therapeutics MedImmune Inc. and many more.
On Thursday, Eledon shares closed at $1.3, down 2.25% on Nasdaq.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.